Publications by authors named "Ellen Filvaroff"

Claim this Profile
A
Author Correction: Shallow shotgun sequencing reduces technical variation in microbiome analysis.
Alex J La Reau, Noah B Strom, Ellen Filvaroff, Konstantinos Mavrommatis, Tonya L Ward

Sci Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TACH101, a first-in-class pan-inhibitor of KDM4 histone demethylase.
Chandtip Chandhasin, Van Dang, Frank Perabo, Joselyn Del Rosario, Young K Chen, Ellen Filvaroff

Anticancer Drugs· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study.
Victor Moreno, Juan Manuel Sepúlveda, David A Reardon, Ángel Pérez-Núñez, Pedro González León, Ellen Filvaroff

Neuro Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shallow shotgun sequencing reduces technical variation in microbiome analysis.
Alex J La Reau, Noah B Strom, Ellen Filvaroff, Konstantinos Mavrommatis, Tonya L Ward

Sci Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas.
Victor Moreno, Maria Vieito, Juan Manuel Sepulveda, Vladimir Galvao, Tatiana Hernández-Guerrero, Ellen Filvaroff

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma.
Alexander C Leeksma, Ingrid A M Derks, Brett Garrick, Aldo Jongejan, Martino Colombo, Ellen H Filvaroff

Mol Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma.
Maria Vieito, Matteo Simonelli, Filip de Vos, Victor Moreno, Marjolein Geurts, Ellen Filvaroff

Neurooncol Adv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies.
Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Patricia Niccoli, Jaume Capdevila, Ellen H Filvaroff

Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma.
Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Nicolas Isambert, Patricia Niccoli, Ellen H Filvaroff

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.
Edward Wolin, Alain Mita, Amit Mahipal, Tim Meyer, Johanna Bendell, Ellen H Filvaroff

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy.
Pamela Munster, Monica Mita, Amit Mahipal, John Nemunaitis, Christophe Massard, Ellen H Filvaroff

Cancer Manag Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway.
Vishal Kothari, Jonathan F Goodwin, Shuang G Zhao, Justin M Drake, Yi Yin, Ellen H Filvaroff

Clin Cancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies.
Emanuela Dylgjeri, Christopher McNair, Jonathan F Goodwin, Heather K Raymon, Peter A McCue, Ellen H Filvaroff

Clin Cancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance.
Ida Aronchik, Yumin Dai, Matt Labenski, Carmen Barnes, Terri Jones, Ellen H Filvaroff

Mol Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.
Rachel Thijssen, Johanna Ter Burg, Brett Garrick, Gregor G W van Bochove, Jennifer R Brown, Ellen H Filvaroff

Blood· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation.
Tom T Chen, Ellen Filvaroff, Jing Peng, Scot Marsters, Adrian Jubb

EBioMedicine· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A technology platform to assess multiple cancer agents simultaneously within a patient's tumor.
Richard A Klinghoffer, S Bahram Bahrami, Beryl A Hatton, Jason P Frazier, Alicia Moreno-Gonzalez, Ellen H Filvaroff

Sci Transl Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefit.
Hartmut Koeppen, Wei Yu, Jiping Zha, Ajay Pandita, Elicia Penuel, Ellen Filvaroff

Clin Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical evaluation of the serum pharmacodynamic biomarkers HGF and shed MET following dosing with the anti-MET monovalent monoclonal antibody onartuzumab.
Elaine Mai, Zhong Zheng, Youjun Chen, Jing Peng, Christophe Severin, Ellen Filvaroff

Mol Cancer Ther· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1.
Ai-Luen Wu, Ganesh Kolumam, Scott Stawicki, Yongmei Chen, Jun Li, Ellen Filvaroff

Sci Transl Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viable tumor tissue detection in murine metastatic breast cancer by whole-body MRI and multispectral analysis.
Kai H Barck, Brandon Willis, Jed Ross, Dorothy M French, Ellen H Filvaroff

Magn Reson Med· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel therapeutic targets along the Th17 pathway.
Wenjun Ouyang, Ellen Filvaroff, Yan Hu, Jane Grogan

Eur J Immunol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking neuropilin-2 function inhibits tumor cell metastasis.
Maresa Caunt, Judy Mak, Wei-Ching Liang, Scott Stawicki, Qi Pan, Ellen H Filvaroff

Cancer Cell· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Egfl7 in vascular morphogenesis.
Maike Schmidt, Ann De Mazière, Tanya Smyczek, Alane Gray, Leon Parker, Ellen Filvaroff

Novartis Found Symp· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-beta regulates the mechanical properties and composition of bone matrix.
Guive Balooch, Mehdi Balooch, Ravi K Nalla, Stephen Schilling, Ellen H Filvaroff

Proc Natl Acad Sci U S A· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis